(Q36529269)

14 August 2017

1 reference

title

Multi-drug resistance genes in the management of neoplastic disease (English)

1 reference

14 August 2017

Multi-Drug Resistance Genes in the Management of Neoplastic Disease (English)

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

28 October 2022

main subject

multiple drug resistance

1 reference

J. Stewart

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682490

28 October 2022

N. T. Gorman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682490

28 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1682490

28 October 2022

publication date

1 July 1991

1 reference

full work available at URL

14 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1939-1676.1991.tb00955.x

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1939-1676.1991.tb00955.x/fullpdf

28 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Journal of Veterinary Internal Medicine

28 October 2022

published in

1 reference

14 August 2017

5

1 reference

14 August 2017

4

1 reference

14 August 2017

239-247

1 reference

The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.1991.TB00955.X

Simultaneous expression of two P-glycoprotein genes in drug-sensitive Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.1991.TB00955.X

Structure and expression of the human MDR (P-glycoprotein) gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.1991.TB00955.X

Cloning and characterization of a second member of the mouse mdr gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.1991.TB00955.X

High-level expression of MRK 16 and MRK 20 murine monoclonal antibody-define proteins (170,000-180,000 P-glycoprotein and 85,000 protein) in leukaemias and malignant lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.1991.TB00955.X

Expression of mdr1 and gst-pi in human breast tumours: comparison to in vitro chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.1991.TB00955.X

Amiodarone is more efficient than verapamil in reversing resistance to anthracyclines in tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.1991.TB00955.X

Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/316820A0

Chlorambucil effectively induces deletion mutations in mouse germ cells

6

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Testicular relapse in childhood acute lymphoblastic leukemia: association with pretreatment patient characteristics and treatment. A report for Childrens Cancer Study Group

28 October 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Optimizing drug delivery to brain tumors

28 October 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Pharmacologic rationale for regional drug delivery.

28 October 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Delivery of novel therapeutic agents in tumors: physiological barriers and strategies

28 October 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Reduced permeability in CHO cells as a mechanism of resistance to colchicine

28 October 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

The clinical pharmacology of methotrexate

28 October 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Amplification and organization of dihydrofolate reductase genes in a human leukemic cell line, K-562, resistant to methotrexate

28 October 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Gene amplification in a leukemic patient treated with methotrexate

28 October 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Role of the Glutathione Redox Cycle in Acquired and de Novo Multidrug Resistance

28 October 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects.

28 October 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines

28 October 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.

28 October 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Mediation of multi-drug resistance in a Chinese hamster ovary cell line by a mutant type II topoisomerase

28 October 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Multiple mechanisms of adriamycin resistance in the human leukemia cell line CCRF-CEM.

28 October 2022

29

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Fundamental studies with cisplatin

28 October 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Increase in nonspecific adsorptive endocytosis in anthracycline- and vinca alkaloid-resistant Ehrlich ascites tumor cell lines.

28 October 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Effect of cell-cell interactions on drug sensitivity and growth of drug-sensitive and -resistant tumor cells in spheroids.

28 October 2022

34

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

28 October 2022

Multidrug resistance

35

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of action.

28 October 2022

36

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Altered thymidylate synthetase in 5-fluorodeoxyuridine-resistant ehrlich ascites carcinoma cells

28 October 2022

37

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Importance of the DNA repair enzyme O6-alkyl guanine alkyltransferase (AT) in cancer chemotherapy.

28 October 2022

40

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity

28 October 2022

42

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Uptake and binding of vincristine by murine leukemia cells

28 October 2022

43

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Mode of action of calcium antagonists which alter anthracycline resistance.

28 October 2022

47

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells

28 October 2022

48

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

28 October 2022

49

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cells

28 October 2022

50

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Over-expression of MDR1 gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell line

28 October 2022

52

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification

28 October 2022

53

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins

28 October 2022

56

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

28 October 2022

57

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance

28 October 2022

58

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum

28 October 2022

59

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Identification of the cystic fibrosis gene: chromosome walking and jumping

28 October 2022

60

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

28 October 2022

61

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Identification of the cystic fibrosis gene: genetic analysis

28 October 2022

62

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Isolation and expression of a complementary DNA that confers multidrug resistance

28 October 2022

63

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Retroviral transfer of a murine cDNA for multidrug resistance confers pleiotropic drug resistance to cells without prior drug selection

28 October 2022

65

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells

28 October 2022

66

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene

28 October 2022

69

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Sequence of mdr3 cDNA encoding a human P-glycoprotein

28 October 2022

75

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

28 October 2022

78

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia.

28 October 2022

79

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

28 October 2022

82

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Expression of the mdr (P-glycoprotein) gene in Chinese hamster digestive tracts

28 October 2022

83

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

28 October 2022

84

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Multiple-drug resistance in human cancer

28 October 2022

85

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus

28 October 2022

86

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Correlation of MDR1 gene expression with chemotherapy in neuroblastoma.

28 October 2022

89

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

MDR1 gene expression in lung cancer.

28 October 2022

90

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Expression of a multidrug-resistance gene in human tumors and tissues

28 October 2022

93

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Expression of a multidrug resistance gene in human cancers

28 October 2022

94

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants

28 October 2022

95

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene.

28 October 2022

96

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Measurement of Multidrug-Resistance Messenger RNA in Urogenital Cancers; Elevated Expression in Renal Cell Carcinoma is Associated with Intrinsic Drug Resistance

28 October 2022

97

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Increased P-glycoprotein expression and multidrug-resistant gene (mdr1) amplification are infrequently found in fresh acute leukemia cells. Sequential analysis of 15 cases at initial presentation and relapsed stage

28 October 2022

100

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining

28 October 2022

102

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

P-glycoprotein in human sarcoma: evidence for multidrug resistance

28 October 2022

104

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Non-chemotherapeutic agents that potentiate chemotherapy efficacy

28 October 2022

114

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil

28 October 2022

115

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Analysis of structural features of dihydropyridine analogs needed to reverse multidrug resistance and to inhibit photoaffinity labeling of P-glycoprotein

28 October 2022

119

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance

28 October 2022

121

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients

28 October 2022

126

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Multidrug resistance: P-glycoprotein and its allies--the elusive foes.

28 October 2022

128

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Multidrug resistance: molecular biology and clinical relevance.

28 October 2022

129

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Clinical trials of agents that reverse multidrug-resistance

28 October 2022

134

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells

28 October 2022

136

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial

28 October 2022

137

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistance.

28 October 2022

139

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Potentiation of chemotherapeutic effect of vincristine in vincristine resistant tumor bearing mice by calmodulin inhibitor clomipramine

28 October 2022

140

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Reversal of drug resistance by erythromycin: erythromycin increases the accumulation of actinomycin D and doxorubicin in multidrug-resistant cells.

28 October 2022

144

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

28 October 2022

145

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas

28 October 2022

146

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver.

28 October 2022

147

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

New principle for the analysis of chemical carcinogenesis

28 October 2022

148

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics.

28 October 2022

149

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Multidrug resistance during chemical carcinogenesis: a mechanism revealed?

28 October 2022

150

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

P450 genes: structure, evolution, and regulation

28 October 2022

151

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Transformation of rat liver epithelial cells with v-H-ras or v-raf causes expression of MDR-1, glutathione-S-transferase-P and increased resistance to cytotoxic chemicals.

28 October 2022

152

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Prevalence of ras gene mutations in human colorectal cancers

28 October 2022

153

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

ras oncogenes in human cancer: a review

28 October 2022

154

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

Oncogene activation in chemical carcinogenesis

28 October 2022

155

1 reference

https://api.crossref.org/works/10.1111/J.1939-1676.1991.TB00955.X

28 October 2022

Identifiers

1 reference

14 August 2017

1 reference